Highly sensitive immunoassay based on a monoclonal antibody specific for [4-arginine] microcystins
A Zeck, A Eikenberg, MG Weller, R Niessner - Analytica Chimica Acta, 2001 - Elsevier
The production and characterization of a monoclonal antibody (clone (MC10E7)) with
extraordinary sensitivity and high selectivity for [4-arginine]microcystins is described. The …
extraordinary sensitivity and high selectivity for [4-arginine]microcystins is described. The …
Generic microcystin immunoassay based on monoclonal antibodies against Adda
A Zeck, MG Weller, D Bursill, R Niessner - Analyst, 2001 - pubs.rsc.org
A monoclonal antibody (clone AD4G2) was generated against a common part of
microcystins and nodularins, the unusual amino acid Adda [(2S,3S,8S,9S)-3-amino-9-methoxy-2,6,8-…
microcystins and nodularins, the unusual amino acid Adda [(2S,3S,8S,9S)-3-amino-9-methoxy-2,6,8-…
NeutrobodyPlex—monitoring SARS‐CoV‐2 neutralizing immune responses using nanobodies
…, H Schweizer, S Nueske, A Scholz, A Zeck… - EMBO …, 2021 - embopress.org
In light of the COVID‐19 pandemic, there is an ongoing need for diagnostic tools to monitor
the immune status of large patient cohorts and the effectiveness of vaccination campaigns. …
the immune status of large patient cohorts and the effectiveness of vaccination campaigns. …
Cell Type-Specific and Site Directed N-Glycosylation Pattern of FcγRIIIa
A Zeck, G Pohlentz, T Schlothauer… - Journal of proteome …, 2011 - ACS Publications
Human leukocyte receptor IIIa (hFcγRIIIa) plays a prominent role in the elimination of tumor
cells by antibody-based cancer therapies. In previous studies, a major impact of the …
cells by antibody-based cancer therapies. In previous studies, a major impact of the …
[HTML][HTML] Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity
…, H Dinter, J Häring, S Ghozzi, A Zeck… - Nature …, 2021 - nature.com
The humoral immune response to SARS-CoV-2 is a benchmark for immunity and detailed
analysis is required to understand the manifestation and progression of COVID-19, monitor …
analysis is required to understand the manifestation and progression of COVID-19, monitor …
MASP-1 and MASP-2 do not activate pro–factor D in resting human blood, whereas MASP-3 is a potential activator: Kinetic analysis involving specific MASP-1 and …
…, D Szakács, A Kocsis, S Dammeier, A Zeck… - The Journal of …, 2016 - journals.aai.org
It had been thought that complement factor D (FD) is activated at the site of synthesis, and
only FD lacking a propeptide is present in blood. The serum of mannose-binding lectin–…
only FD lacking a propeptide is present in blood. The serum of mannose-binding lectin–…
[HTML][HTML] Single-Domain Antibodies for Targeting, Detection, and In Vivo Imaging of Human CD4+ Cells
…, Y Parfyonova, S Nueske, AM Scholz, A Zeck… - Frontiers in …, 2021 - frontiersin.org
The advancement of new immunotherapies necessitates appropriate probes to monitor the
presence and distribution of distinct immune cell populations. Considering the key role of …
presence and distribution of distinct immune cell populations. Considering the key role of …
Antibody binding and angiotensin-converting enzyme 2 binding inhibition Is significantly reduced for both the BA. 1 and BA. 2 Omicron variants
Background The rapid emergence of the Omicron variant and its large number of mutations
led to its classification as a variant of concern (VOC) by the World Health Organization. …
led to its classification as a variant of concern (VOC) by the World Health Organization. …
[HTML][HTML] Discovery of Highly Active Recombinant PNGase H+ Variants Through the Rational Exploration of Unstudied Acidobacterial Genomes
…, M Gramlich, YM Du, T Wang, A Zeck… - … in bioengineering and …, 2020 - frontiersin.org
Peptide-N 4 -(N-acetyl-β-glucosaminyl) asparagine amidases (PNGases, N-glycanases, EC
3.5.1.52) are indispensable tools in releasing N-glycans from glycoproteins. So far, only a …
3.5.1.52) are indispensable tools in releasing N-glycans from glycoproteins. So far, only a …
[HTML][HTML] HDX-MS for epitope characterization of a therapeutic ANTIBODY candidate on the calcium-binding protein annexin-A1
…, U Rothbauer, D Stoll, S Maier, A Zeck - Antibodies, 2021 - mdpi.com
Annexin-A1 (ANXA1) belongs to a class of highly homologous Ca 2+ -dependent
phospholipid-binding proteins. Its structure consists of a core region composed of four homologous …
phospholipid-binding proteins. Its structure consists of a core region composed of four homologous …